Brief: Finch Therapeutics Group Preliminarily Estimates That Its Cash And Cash Equivalents As Of Dec 31, 2021 Was About $133.5 Mln
10/01/2022 13:32
Jan 10 (Reuters) - Finch Therapeutics Group Inc FNCH.O :
* FINCH THERAPEUTICS GROUP - PRELIMINARILY ESTIMATES THAT
ITS CASH
AND CASH EQUIVALENTS AS OF DEC 31, 2021 WAS ABOUT $133.5 MILLION
Source text for Eikon: ID:
Further company coverage: FNCH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Finch Therapeutics
See all newsFinch wins US jury trial against Ferring over fecal-transplant patents
Brief: Finch Therapeutics Group Received A Notice From Nasdaq Acknowledging Fact That Co Does Not Meet Requirements Of Rules On April 2
Brief: Finch Therapeutics Got Letter From Nasdaq That Co Has Regained Compliance With Nasdaq’s Listing Rule 5450(A)(1)
U.S. STOCKS ON THE MOVE-Gold miners, ImmunoGen, Oracle
U.S. STOCKS ON THE MOVE-Teekay, gold miners, Oil-Dri Corp